Small, J., Washburn, E., Millington, K., Zhu, J., & Holder, S. L. (2017). The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors. Oncotarget.

Small, Jeffrey, Erik Washburn, Karmaine Millington, Junjia Zhu, und Sheldon L. Holder. "The Addition of Abemaciclib to Sunitinib Induces Regression of Renal Cell Carcinoma Xenograft Tumors." Oncotarget 2017.

Small, Jeffrey, et al. "The Addition of Abemaciclib to Sunitinib Induces Regression of Renal Cell Carcinoma Xenograft Tumors." Oncotarget 2017.